2023 Regular SessionIndiana Legislature

SB0008: Prescription drug rebates and pricing.

Legislative Summary

Prescription drug rebates and pricing. Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.

Bill History

1/9/2023
Authored by Senator Charbonneau
Senate
1/9/2023
First reading: referred to Committee on Health and Provider Services
Senate
1/30/2023
Senator Bohacek added as second author
Senate
1/30/2023
Senator Becker added as third author
Senate
2/13/2023
Senator Busch added as coauthor
Senate
2/14/2023
Senators Donato and Johnson added as coauthors
Senate
2/16/2023
Committee report: do pass, adopted
Senate
2/16/2023
Senator Crider added as coauthor
Senate
2/20/2023
Amendment #1 (Charbonneau) prevailed; voice vote
Senate
2/20/2023
Second reading: amended, ordered engrossed
Senate
2/21/2023
Senator Randolph added as coauthor
Senate
2/23/2023
Third reading: passed; Roll Call 153: yeas 42, nays 5
Senate
2/23/2023
House sponsor: Representative Schaibley
Senate
2/23/2023
Cosponsor: Representative Barrett
Senate
2/24/2023
Referred to the House
Senate
2/28/2023
First reading: referred to Committee on Insurance
House of Representatives
3/13/2023
Representative Olthoff added as cosponsor
House of Representatives
4/6/2023
Committee report: amend do pass, adopted
House of Representatives
4/11/2023
Amendment #1 (Schaibley) prevailed; voice vote
House of Representatives
4/11/2023
Representative Porter added as cosponsor
House of Representatives
4/11/2023
Second reading: amended, ordered engrossed
House of Representatives
4/12/2023
Third reading: passed; Roll Call 406: yeas 94, nays 0
House of Representatives
4/12/2023
Returned to the Senate with amendments
House of Representatives
4/13/2023
Motion to dissent filed
Senate
4/13/2023
Senate dissented from House amendments
Senate
4/18/2023
House conferees appointed: Carbaugh and Shackleford
House of Representatives
4/18/2023
House advisors appointed: Barrett, Lehman, Schaibley and Porter
House of Representatives
4/19/2023
Senate conferees appointed: Charbonneau and Breaux
Senate
4/19/2023
Senate advisors appointed: Melton and Bohacek
Senate
4/27/2023
Representative Schaibley removed as advisor
House of Representatives
4/27/2023
Representative Carbaugh removed as conferee
House of Representatives
4/27/2023
Representative Schaibley added as conferee
House of Representatives
4/27/2023
CCR # 1 filed in the Senate
Senate
4/27/2023
CCR # 1 filed in the House
House of Representatives
4/27/2023
Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 550: yeas 72, nays 21
House of Representatives
4/27/2023
Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 525: yeas 40, nays 9
Senate
4/27/2023
Senator Johnson removed as coauthor
Senate
4/28/2023
Signed by the President Pro Tempore
Senate
4/28/2023
Signed by the President of the Senate
Senate
5/1/2023
Signed by the Speaker
House of Representatives
5/4/2023
Signed by the Governor
Senate
5/4/2023
Public Law 166
Senate

Roll Call Votes

House - Rules Suspended. Conference Committee Report 1
4/27/2023
72
Yea
21
Nay
1
Not Voting
6
Absent
Result: PASSED
Senate - Rules Suspended. Conference Committee Report 1
4/27/2023
40
Yea
9
Nay
1
Not Voting
0
Absent
Result: PASSED
House - Third reading
4/12/2023
94
Yea
0
Nay
1
Not Voting
5
Absent
Result: PASSED
Senate - Third reading
2/23/2023
42
Yea
5
Nay
1
Not Voting
2
Absent
Result: PASSED

Status Information

Current Status
Passed(5/4/2023)
Chamber
Senate
Sine DiePrior Session

Documents

Enrolled
Bill Text4/27/2023135.0 KB
Engrossed
Bill Text4/11/2023221.8 KB
Amended
Bill Text4/6/2023185.9 KB
Engrossed
Bill Text2/20/2023171.2 KB
Amended
Bill Text2/16/2023146.4 KB
Introduced
Bill Text1/9/2023128.7 KB